シクレソニドの世界市場 2020年

• 英文タイトル：Global Ciclesonide Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201113868 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、シクレソニドの世界市場を調査対象にし、シクレソニドの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（吸入エアロゾル37mcg/作動、吸入エアロゾル80mcg/作動、吸入エアロゾル120mcg/作動、吸入エアロゾル160mcg/作動）、用途別分析（大人、子供）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Covis Pharma ・企業別売上、市場シェア ・シクレソニドの地域別市場分析 ・シクレソニドの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・シクレソニドのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・シクレソニドのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・シクレソニドの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・シクレソニドの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・シクレソニドの種類別市場規模2015-2020：吸入エアロゾル37mcg/作動、吸入エアロゾル80mcg/作動、吸入エアロゾル120mcg/作動、吸入エアロゾル160mcg/作動 ・シクレソニドの用途別市場規模2015-2020：大人、子供 ・シクレソニドの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Ciclesonide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Ciclesonide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Ciclesonide market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Ciclesonide market has been segmented into:
Inhalation Aerosol 37 mcg/actuation
Inhalation Aerosol 80 mcg/actuation
Inhalation Aerosol 120 mcg/actuation
Inhalation Aerosol 160 mcg/actuation

By Application, Ciclesonide has been segmented into:
Adults
Children

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ciclesonide market presented in the report. This section sheds light on the sales growth of different regional and country-level Ciclesonide markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ciclesonide market.

The report offers in-depth assessment of the growth and other aspects of the Ciclesonide market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Ciclesonide Market Share Analysis
Ciclesonide competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ciclesonide sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ciclesonide sales, revenue and market share for each player covered in this report.

The major players covered in Ciclesonide are:
Covis Pharma

レポート目次

---

1 Ciclesonide Market Overview
1.1 Product Overview and Scope of Ciclesonide
1.2 Classification of Ciclesonide by Type
1.2.1 Global Ciclesonide Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Ciclesonide Revenue Market Share by Type in 2019
1.2.3 Inhalation Aerosol 37 mcg/actuation
1.2.4 Inhalation Aerosol 80 mcg/actuation
1.2.5 Inhalation Aerosol 120 mcg/actuation
1.2.6 Inhalation Aerosol 160 mcg/actuation
1.3 Global Ciclesonide Market by Application
1.3.1 Overview: Global Ciclesonide Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Adults
1.3.3 Children
1.4 Global Ciclesonide Market by Regions
1.4.1 Global Ciclesonide Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Ciclesonide (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Ciclesonide Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Ciclesonide Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ciclesonide Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Ciclesonide Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ciclesonide Status and Prospect (2015-2025)
2 Company Profiles
2.1 Covis Pharma
2.1.1 Covis Pharma Details
2.1.2 Covis Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Covis Pharma SWOT Analysis
2.1.4 Covis Pharma Product and Services
2.1.5 Covis Pharma Ciclesonide Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Ciclesonide Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Ciclesonide Players Market Share
3.2.2 Top 10 Ciclesonide Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Ciclesonide Revenue and Market Share by Regions
4.2 North America Ciclesonide Revenue and Growth Rate (2015-2020)
4.3 Europe Ciclesonide Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Ciclesonide Revenue and Growth Rate (2015-2020)
4.5 South America Ciclesonide Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Ciclesonide Revenue and Growth Rate (2015-2020)
5 North America Ciclesonide Revenue by Countries
5.1 North America Ciclesonide Revenue by Countries (2015-2020)
5.2 USA Ciclesonide Revenue and Growth Rate (2015-2020)
5.3 Canada Ciclesonide Revenue and Growth Rate (2015-2020)
5.4 Mexico Ciclesonide Revenue and Growth Rate (2015-2020)
6 Europe Ciclesonide Revenue by Countries
6.1 Europe Ciclesonide Revenue by Countries (2015-2020)
6.2 Germany Ciclesonide Revenue and Growth Rate (2015-2020)
6.3 UK Ciclesonide Revenue and Growth Rate (2015-2020)
6.4 France Ciclesonide Revenue and Growth Rate (2015-2020)
6.5 Russia Ciclesonide Revenue and Growth Rate (2015-2020)
6.6 Italy Ciclesonide Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Ciclesonide Revenue by Countries
7.1 Asia-Pacific Ciclesonide Revenue by Countries (2015-2020)
7.2 China Ciclesonide Revenue and Growth Rate (2015-2020)
7.3 Japan Ciclesonide Revenue and Growth Rate (2015-2020)
7.4 Korea Ciclesonide Revenue and Growth Rate (2015-2020)
7.5 India Ciclesonide Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Ciclesonide Revenue and Growth Rate (2015-2020)
8 South America Ciclesonide Revenue by Countries
8.1 South America Ciclesonide Revenue by Countries (2015-2020)
8.2 Brazil Ciclesonide Revenue and Growth Rate (2015-2020)
8.3 Argentina Ciclesonide Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Ciclesonide by Countries
9.1 Middle East & Africa Ciclesonide Revenue by Countries (2015-2020)
9.2 Saudi Arabia Ciclesonide Revenue and Growth Rate (2015-2020)
9.3 UAE Ciclesonide Revenue and Growth Rate (2015-2020)
9.4 Egypt Ciclesonide Revenue and Growth Rate (2015-2020)
9.5 South Africa Ciclesonide Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Ciclesonide Revenue and Market Share by Type (2015-2020)
10.2 Global Ciclesonide Market Forecast by Type (2019-2024)
10.3 Inhalation Aerosol 37 mcg/actuation Revenue Growth Rate (2015-2025)
10.4 Inhalation Aerosol 80 mcg/actuation Revenue Growth Rate (2015-2025)
10.5 Inhalation Aerosol 120 mcg/actuation Revenue Growth Rate (2015-2025)
10.6 Inhalation Aerosol 160 mcg/actuation Revenue Growth Rate (2015-2025)
11 Global Ciclesonide Market Segment by Application
11.1 Global Ciclesonide Revenue Market Share by Application (2015-2020)
11.2 Ciclesonide Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2015-2020)
11.4 Children Revenue Growth (2015-2020)
12 Global Ciclesonide Market Size Forecast (2021-2025)
12.1 Global Ciclesonide Market Size Forecast (2021-2025)
12.2 Global Ciclesonide Market Forecast by Regions (2021-2025)
12.3 North America Ciclesonide Revenue Market Forecast (2021-2025)
12.4 Europe Ciclesonide Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Ciclesonide Revenue Market Forecast (2021-2025)
12.6 South America Ciclesonide Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Ciclesonide Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Ciclesonide Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ciclesonide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ciclesonide Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Ciclesonide Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Covis Pharma Corporate Information, Location and Competitors
Table 6. Covis Pharma Ciclesonide Major Business
Table 7. Covis Pharma Ciclesonide Total Revenue (USD Million) (2017-2018)
Table 8. Covis Pharma SWOT Analysis
Table 9. Covis Pharma Ciclesonide Product and Solutions
Table 10. Covis Pharma Ciclesonide Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Ciclesonide Revenue (Million USD) by Players (2015-2020)
Table 12. Global Ciclesonide Revenue Share by Players (2015-2020)
Table 13. Global Ciclesonide Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Ciclesonide Revenue Market Share by Regions (2015-2020)
Table 15. North America Ciclesonide Revenue by Countries (2015-2020)
Table 16. North America Ciclesonide Revenue Market Share by Countries (2015-2020)
Table 17. Europe Ciclesonide Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Ciclesonide Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Ciclesonide Revenue by Countries (2015-2020)
Table 20. South America Ciclesonide Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Ciclesonide Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Ciclesonide Revenue Market Share by Countries (2015-2020)
Table 23. Global Ciclesonide Revenue (Million USD) by Type (2015-2020)
Table 24. Global Ciclesonide Revenue Share by Type (2015-2020)
Table 25. Global Ciclesonide Revenue Forecast by Type (2021-2025)
Table 26. Global Ciclesonide Revenue by Application (2015-2020)
Table 27. Global Ciclesonide Revenue Share by Application (2015-2020)
Table 28. Global Ciclesonide Revenue Forecast by Application (2021-2025)
Table 29. Global Ciclesonide Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Ciclesonide Picture
Figure 2. Global Ciclesonide Revenue Market Share by Type in 2019
Figure 3. Inhalation Aerosol 37 mcg/actuation Picture
Figure 4. Inhalation Aerosol 80 mcg/actuation Picture
Figure 5. Inhalation Aerosol 120 mcg/actuation Picture
Figure 6. Inhalation Aerosol 160 mcg/actuation Picture
Figure 7. Ciclesonide Revenue Market Share by Application in 2019
Figure 8. Adults Picture
Figure 9. Children Picture
Figure 10. Global Ciclesonide Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Ciclesonide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Ciclesonide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Ciclesonide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Ciclesonide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Ciclesonide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Ciclesonide Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Ciclesonide Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Ciclesonide Revenue Market Share in 2019
Figure 19. Global Top 10 Players Ciclesonide Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Ciclesonide Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Ciclesonide Revenue Market Share by Regions (2015-2020)
Figure 23. Global Ciclesonide Revenue Market Share by Regions in 2018
Figure 24. North America Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 25. Europe Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 27. South America Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 29. North America Ciclesonide Revenue Market Share by Countries (2015-2020)
Figure 30. North America Ciclesonide Revenue Market Share by Countries in 2019
Figure 31. USA Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 32. Canada Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 34. Europe Ciclesonide Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Ciclesonide Revenue Market Share by Countries in 2019
Figure 36. Germany Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 37. UK Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 38. France Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 39. Russia Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 40. Italy Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Ciclesonide Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Ciclesonide Revenue Market Share by Countries in 2019
Figure 43. China Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 44. Japan Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 45. Korea Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 46. India Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 48. South America Ciclesonide Revenue Market Share by Countries (2015-2020)
Figure 49. South America Ciclesonide Revenue Market Share by Countries in 2019
Figure 50. Brazil Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Ciclesonide Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Ciclesonide Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 55. UAE Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Ciclesonide Revenue and Growth Rate (2015-2020)
Figure 58. Global Ciclesonide Revenue Share by Type (2015-2020)
Figure 59. Global Ciclesonide Revenue Share by Type in 2019
Figure 60. Global Ciclesonide Market Share Forecast by Type (2021-2025)
Figure 61. Global Inhalation Aerosol 37 mcg/actuation Revenue Growth Rate (2015-2020)
Figure 62. Global Inhalation Aerosol 80 mcg/actuation Revenue Growth Rate (2015-2020)
Figure 63. Global Inhalation Aerosol 120 mcg/actuation Revenue Growth Rate (2015-2020)
Figure 64. Global Inhalation Aerosol 160 mcg/actuation Revenue Growth Rate (2015-2020)
Figure 65. Global Ciclesonide Revenue Share by Application (2015-2020)
Figure 66. Global Ciclesonide Revenue Share by Application in 2019
Figure 67. Global Ciclesonide Market Share Forecast by Application (2021-2025)
Figure 68. Global Adults Revenue Growth Rate (2015-2020)
Figure 69. Global Children Revenue Growth Rate (2015-2020)
Figure 70. Global Ciclesonide Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Ciclesonide Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Ciclesonide Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Ciclesonide Revenue Market Forecast (2021-2025)
Figure 74. Europe Ciclesonide Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Ciclesonide Revenue Market Forecast (2021-2025)
Figure 76. South America Ciclesonide Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Ciclesonide Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---